Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

Multimedia

Millie Long, MD
Videos
Millie Long, MD, on the Evolution of Evidence-Based Management of IBD
04/02/2022
Dr Long gives an overview of her keynote address at the AIBD 2022 Regionals Meeting in Raleigh, North Carolina, where she looked back at the past 20 years of evidence-based IBD management and mapped out what the future could look like for the...
Dr Long gives an overview of her keynote address at the AIBD 2022 Regionals Meeting in Raleigh, North Carolina, where she looked back at the past 20 years of evidence-based IBD management and mapped out what the future could look like for the...
Dr Long gives an overview of her...
04/02/2022
Advances in Inflammatory Bowel Disease Network
Sara Horst
Video
Sara Horst, MD, on IL-12/23 and IL-23 Receptor Antagonists for Treatment of IBD
04/02/2022
Dr Horst, from Vanderbilt Medical Center, recaps her presentation from the Advances in Inflammatory Bowel Diseases regional meeting on using IL-12/23 and IL-23 receptor antagonists in treating IBD.
Dr Horst, from Vanderbilt Medical Center, recaps her presentation from the Advances in Inflammatory Bowel Diseases regional meeting on using IL-12/23 and IL-23 receptor antagonists in treating IBD.
Dr Horst, from Vanderbilt...
04/02/2022
Advances in Inflammatory Bowel Disease Network
Raymond Cross, MD
Videos
Raymond Cross, MD, on Leukocyte Trafficking
04/02/2022
Dr Cross reviews his presentation on leukocyte trafficking in treatment for inflammatory bowel disease from the Advances in Inflammatory Bowel Disease Regional Meeting on April 2, 2022.
Dr Cross reviews his presentation on leukocyte trafficking in treatment for inflammatory bowel disease from the Advances in Inflammatory Bowel Disease Regional Meeting on April 2, 2022.
Dr Cross reviews his...
04/02/2022
Advances in Inflammatory Bowel Disease Network
Sara Horst
Video
Sara Horst, MD, on Risk Stratification and Disease Monitoring for Patients With IBD
04/02/2022
Dr Horst, from Vanderbilt University Medical Center, reviews her presentation from the Advances in Inflammatory Bowel Diseases regional meeting about how risk stratification and disease monitoring can improve outcomes among patients with IBD.
Dr Horst, from Vanderbilt University Medical Center, reviews her presentation from the Advances in Inflammatory Bowel Diseases regional meeting about how risk stratification and disease monitoring can improve outcomes among patients with IBD.
Dr Horst, from Vanderbilt...
04/02/2022
Advances in Inflammatory Bowel Disease Network
Hudesman
Video
David Hudesman, MD, on Luminal Crohn Disease in 2022
04/02/2022
Dr Hudesman, from NYU Langone Health, discussed the management of Crohn disease at the Advances in Inflammatory Bowel Diseases regional meeting on April 2.
Dr Hudesman, from NYU Langone Health, discussed the management of Crohn disease at the Advances in Inflammatory Bowel Diseases regional meeting on April 2.
Dr Hudesman, from NYU Langone...
04/02/2022
Advances in Inflammatory Bowel Disease Network
Florian Rieder, MD
Videos
Florian Rieder, MD, on The IBD Endoscopic Toolbox
03/31/2022
Dr Rieder recaps his presentation on the key considerations needed for the IBD Endoscopic Toolbox from the Advances in Inflammatory Bowel Disease 2022 Regional Meeting.
Dr Rieder recaps his presentation on the key considerations needed for the IBD Endoscopic Toolbox from the Advances in Inflammatory Bowel Disease 2022 Regional Meeting.
Dr Rieder recaps his...
03/31/2022
Advances in Inflammatory Bowel Disease Network
Raymond Cross, MD
Videos
Raymond Cross, MD, on Therapeutic Drug Monitoring in IBD
03/30/2022
Dr Cross gives an overview of his talk on therapeutic drug monitoring in IBD from the Advances in Inflammatory Bowel Disease 2022 Regional Meeting.
Dr Cross gives an overview of his talk on therapeutic drug monitoring in IBD from the Advances in Inflammatory Bowel Disease 2022 Regional Meeting.
Dr Cross gives an overview of...
03/30/2022
Advances in Inflammatory Bowel Disease Network
Oriana Damas, MD
Podcasts
IBD Drive Time: Oriana Damas, MD, on Treating Underserved Patients with IBD
03/24/2022
In this episode of IBD Drive Time, Oriana Damas, MD, discusses what to be aware of when treating patients from underserved populations with IBD, as well as minority representation in research, with our hosts, Drs Millie Long and Ray Cross.
In this episode of IBD Drive Time, Oriana Damas, MD, discusses what to be aware of when treating patients from underserved populations with IBD, as well as minority representation in research, with our hosts, Drs Millie Long and Ray Cross.
In this episode of IBD Drive...
03/24/2022
Advances in Inflammatory Bowel Disease Network
Long
Video
Millie Long, MD, Welcomes You to AIBD Live!
03/23/2022
Millie Long, MD, cochair of the Advances in Inflammatory Bowel Diseases (AIBD) LIVE regional meeting on April 2, says welcome to all who are coming to Raleigh, NC, for the first in-person AIBD regional meeting in 2 years!
Millie Long, MD, cochair of the Advances in Inflammatory Bowel Diseases (AIBD) LIVE regional meeting on April 2, says welcome to all who are coming to Raleigh, NC, for the first in-person AIBD regional meeting in 2 years!
Millie Long, MD, cochair of the...
03/23/2022
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Laura Raffals, MD, on Complications of the J-Pouch
03/18/2022
Dr Raffals, from the Mayo Clinic in Rochester, Minnesota, discusses managing the J-pouch and possible complications among patients with hosts Raymond Cross, MD, and Millie Long, MD.
Dr Raffals, from the Mayo Clinic in Rochester, Minnesota, discusses managing the J-pouch and possible complications among patients with hosts Raymond Cross, MD, and Millie Long, MD.
Dr Raffals, from the Mayo Clinic...
03/18/2022
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement

Latest News

News
Impact of Concomitant Medications on Advanced Therapies for Ulcerative Colitis
11/12/2024
Most concomitant medications do not affect the efficacy or safety of advanced therapies in ulcerative colitis clinical trials, according to a recent study.
Most concomitant medications do not affect the efficacy or safety of advanced therapies in ulcerative colitis clinical trials, according to a recent study.
Most concomitant medications do...
11/12/2024
Advances in Inflammatory Bowel Disease Network
News
Assessing Transmural Healing and Response in Patients with Crohn's Disease
11/11/2024
The the modified Clermont score was found to be an easy-to-use tool for assessing transmural healing and transmural response in CD patients.
The the modified Clermont score was found to be an easy-to-use tool for assessing transmural healing and transmural response in CD patients.
The the modified Clermont score...
11/11/2024
Advances in Inflammatory Bowel Disease Network
News
MRE or IUS for Crohn’s Disease Imaging?
11/06/2024
Investigators found patients typically preferred intestinal ultrasound for diagnosis and monitoring of Crohn’s disease, while magnetic resonance enterography may be better for diagnosing relapse.
Investigators found patients typically preferred intestinal ultrasound for diagnosis and monitoring of Crohn’s disease, while magnetic resonance enterography may be better for diagnosing relapse.
Investigators found patients...
11/06/2024
Advances in Inflammatory Bowel Disease Network
News
Lupus and IBD Share Microbiome Features
10/18/2024
Researchers identified distinct microbial signatures with significant overlaps between systemic lupus erythematosus and inflammatory bowel disease.
Researchers identified distinct microbial signatures with significant overlaps between systemic lupus erythematosus and inflammatory bowel disease.
Researchers identified distinct...
10/18/2024
Advances in Inflammatory Bowel Disease Network
News
Standard Dosing of Infliximab Effective for Steroid-Refractory ASUC
10/18/2024
While infliximab proved safe and effective for inducing remission in acute severe ulcerative colitis, higher doses and varied induction strategies showed no significant change in response.
While infliximab proved safe and effective for inducing remission in acute severe ulcerative colitis, higher doses and varied induction strategies showed no significant change in response.
While infliximab proved safe and...
10/18/2024
Advances in Inflammatory Bowel Disease Network
News
The Risks of Placebo in IBD Drug Trials
10/18/2024
Investigators recommend alternative trial designs to reduce potential harms to placebo-receiving patients with inflammatory bowel disease.
Investigators recommend alternative trial designs to reduce potential harms to placebo-receiving patients with inflammatory bowel disease.
Investigators recommend...
10/18/2024
Advances in Inflammatory Bowel Disease Network
News
Endoscopic Healing Index Shows Limited Utility for Identifying CD Remission
10/08/2024
Researchers at the University of Chicago recommend using the EHI with another modality to accurately identify inflammation among patients with Crohn’s disease.
Researchers at the University of Chicago recommend using the EHI with another modality to accurately identify inflammation among patients with Crohn’s disease.
Researchers at the University of...
10/08/2024
Advances in Inflammatory Bowel Disease Network
News
Scores Predict Corticosteroid Failure Risk in Patients With ASUC
10/03/2024
Risk of rescue scores that include several clinical, laboratory, and endoscopic variables may help improve outcomes in patients with acute severe ulcerative colitis.
Risk of rescue scores that include several clinical, laboratory, and endoscopic variables may help improve outcomes in patients with acute severe ulcerative colitis.
Risk of rescue scores that...
10/03/2024
Advances in Inflammatory Bowel Disease Network
News
Previous Stricturing Increases Risk of Anastomotic Stricture in Postoperative CD
10/01/2024
Early detection and treatment are the keys to reducing risk of progressive disease.
Early detection and treatment are the keys to reducing risk of progressive disease.
Early detection and treatment...
10/01/2024
Advances in Inflammatory Bowel Disease Network
News
Ustekinumab Shows Superior Persistence in CD Patients With Prior Biologic Use
09/30/2024
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line...
09/30/2024
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement

Latest Podcasts

Millie Long
Video
Millie Long, MD, on Comparative Effectiveness in Ulcerative Colitis
10/21/2024
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation...
10/21/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Drs James Lewis and Laura Raffals on SPARC
10/21/2024
Dr Raymond Cross hosts Drs James Lewis and Laura Raffals in a discussion of SPARC, a study of adults with inflammatory bowel disease in which patients are followed prospectively to collect data about to allow prediction of disease course and...
Dr Raymond Cross hosts Drs James Lewis and Laura Raffals in a discussion of SPARC, a study of adults with inflammatory bowel disease in which patients are followed prospectively to collect data about to allow prediction of disease course and...
Dr Raymond Cross hosts Drs James...
10/21/2024
Advances in Inflammatory Bowel Disease Network
Freddy Caldera
Podcast
Freddy Caldera, DO, on the RSV Vaccine for Patients With IBD
10/11/2024
Dr Caldera, from the University of Wisconsin School of Medicine, provides an overview of the risks of respiratory syncytial virus to older adults, including patients with IBD, and the importance of ensuring patients receive this vaccine along...
Dr Caldera, from the University of Wisconsin School of Medicine, provides an overview of the risks of respiratory syncytial virus to older adults, including patients with IBD, and the importance of ensuring patients receive this vaccine along...
Dr Caldera, from the University...
10/11/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Updates on the PIANO Study of IBD and Pregnancy
10/07/2024
IBD Drive Time Hosts Millie Long, MD, and Raymond Cross, MD, discuss new recommendations for managing inflammatory bowel disease among pregnant patients or those wanting to conceive, resulting from updates to the landmark PIANO study. 
IBD Drive Time Hosts Millie Long, MD, and Raymond Cross, MD, discuss new recommendations for managing inflammatory bowel disease among pregnant patients or those wanting to conceive, resulting from updates to the landmark PIANO study. 
IBD Drive Time Hosts Millie...
10/07/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: David Hudesman, MD, on Work Productivity in IBD
09/19/2024
Dr David Hudesman of NYU-Langone Health joins IBD Drive Time host Dr Raymond Cross to talk about how inflammatory bowel disease affects work productivity and social activities.
Dr David Hudesman of NYU-Langone Health joins IBD Drive Time host Dr Raymond Cross to talk about how inflammatory bowel disease affects work productivity and social activities.
Dr David Hudesman of NYU-Langone...
09/19/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Erin Forster, MD, on Risankizumab for Ulcerative Colitis
09/03/2024
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Erin Forster of the Medical...
09/03/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Dr Jana Al Hashash on Diet and Nutrition in IBD Care
08/05/2024
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo...
08/05/2024
Advances in Inflammatory Bowel Disease Network
Shubha Bhat
Podcast
Shubha Bhat, PharmD, on the Role of the Clinical Pharmacist in IBD
07/25/2024
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent...
07/25/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: The Best of DDW, Part 2
07/18/2024
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In part 2 of this podcast,...
07/18/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Best of DDW, Part 1
07/09/2024
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...
In the first episode of this...
07/09/2024
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement